Robert C Kleiner, M.D. Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 124 Dekalb Pike, North Wales, PA 19454 Phone: 215-699-7600 Fax: 215-699-4758 |
Mira Amin, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1140 Welsh Rd Ste 220, North Wales, PA 19454 Phone: 215-542-1522 Fax: 215-542-9609 |
Jonathan B Belmont, M.D. Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 124 Dekalb Pike, North Wales, PA 19454 Phone: 215-699-7600 Fax: 215-699-4758 |
News Archive
In this Huffington Post "Global Motherhood" opinion piece, Kate Roberts, vice president of corporate marketing, communications and advocacy at Population Services International, marks International Women's Day, to be recognized on March 8, and its 2012 theme, "Connecting Girls, Inspiring Futures."
Christiana Care Health System has partnered with ColdLight and Medecision to provide more coordinated personalized care to patients with chronic heart disease with breakthrough analytics technology.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
For American teenagers, most text messaging is as harmless as passing notes, but University of Texas at Dallas researchers have discovered that engaging in antisocial texting can actually predict deviant behavior.
National Institutes of Health researchers have uncovered a key factor in understanding the elevated cancer risk associated with gene therapy. They conducted research on mice with a rare disease similar to one in humans, hoping their findings may eventually help improve gene therapy for humans. Researchers at the National Human Genome Research Institute, part of NIH, published their research in the Jan. 20, 2015, online issue of the Journal of Clinical Investigation.
› Verified 5 days ago